Cardiovascular Research

Relation of early mononuclear and polymorphonuclear cell infiltration to late scar thickness after experimentally induced myocar

Authors: C S Roberts|||D Maclean|||P Maroko|||R A Kloner

Affiliations: + Expand

Abstract

This report describes the relationship between the intensity of early inflammation after acute myocardial infarction and the later thickness of the left ventricular (LV) scar. Histologic sections of hearts from methylprednisolone-treated (MP), cobra venom factor-treated (CVF), and untreated control rats that had been subjected to either 2 or 21 days of coronary artery occlusion were studied. In the rats examined at 2 days (n = 20 for MP, n = 16 for CVF, and n = 20 for controls), a semiquantitative inflammation score (1-4) was attributed to each infarct. Mononuclear (MN) cells were counted in 4 oil-immersion fields per section and polymorphonuclear (PMN) cells in 9 oil-immersion fields per section. In the rats examined at 21 days (n = 22 for MP, n = 22 for CVF, and n = 26 for controls), the thickness of the LV scar was measured every 1.6 mm along its circumference. Inflammation scores at 2 days were 3.5 +/- .6 for controls, 1.5 +/- .5 for MP, and 2.9 +/- .8 for CVF (p less than .05 among groups). The MN cells counted were 73 +/- 7 for controls, 47 +/- 5 for MP, and 61 +/- 9 for CVF (p less than .05 among groups). There was no difference in PMN infiltrate among groups. Scar thickness at 21 days were .9 +/- .1 mm for controls, .7 +/- .1 mm for MP, and .9 +/- .1 mm for CVF (MP compared to CVF and controls, p less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)

---

Chemical List

Elapid Venoms|||cobra venom factor|||Methylprednisolone

---

Reference List

J Immunol. 1971 Dec;107(6):1666-72|||J Immunol. 1978 Jan;120(1):109-15|||J Immunol. 1970 Jul;105(1):55-69|||Circulation. 1955 May;11(5):742-8|||J Clin Invest. 1975 Sep;56(3):679-89|||J Clin Invest. 1978 Mar;61(3):541-51|||J Clin Invest. 1978 Mar;61(3):661-70|||Inflammation. 1979 Jul;3(3):329-43|||J Exp Med. 1971 Sep 1;134(3):109-13|||J Clin Invest. 1975 Sep;56(3):740-50|||Adv Nephrol Necker Hosp. 1974;4:15-35|||Lab Invest. 1983 Apr;48(4):436-47|||Am J Med. 1974 Feb;56(2):244-50|||J Exp Med. 1971 Apr 1;133(4):885-900|||Am J Cardiol. 1983 Mar 1;51(5):872-6|||Ann Intern Med. 1976 Mar;84(3):304-15|||N Engl J Med. 1972 Sep 7;287(10):489-95|||Circulation. 1978 Jan;57(1):56-63|||J Clin Invest. 1980 Nov;66(5):1050-6|||Circulation. 1983 Aug;68(2):446-52|||J Exp Med. 1971 Sep 1;134(3):90-108